Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
Neuren Pharmaceuticals Limited
Neuren Pharmaceuticals Limited
NEU · ASX

Neuren Pharmaceuticals Limited

AU$21.40

Price Arrow0.46 (2.20%)
24/10/2025 04:10:02 PM
All-CompaniesAll-ConsensusDefying GravityGROWTH AUSHALO 200HALO Balance SheetHALO OrdsHALO Price Momentum+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Neuren Pharmaceuticals Limited Overview

NEU Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Weak

Garp

Very Weak

Mqv Small

Weak

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Strong

About NEU

icon

Telephone

61.3.9092.0480

icon

Address

Suite 201, 697 Burke Road, Camberwell, Victoria (VIC) 3124

Description

Neuren Pharmaceuticals Ltd. engages in the development of new therapies for neurodevelopmental disorders that emerge in early childhood. It operates through the Commercial Products, and Research and Development segments. The Commercial Products segment refers to the milestone and royalty revenue from license of intellectual property. The Research and Development segment focuses on the development of pharmaceutical products for the treatment of neurodevelopmental disorders. The company was founded on December 17, 2001 and is headquartered in Camberwell, Australia.

NEU Price Chart

Key Stats

Market Cap

AU$2.65B

PE

11.90

EV/EBITDA

9.6

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 8.61 - 22.99

Trade Value (12mth)

AU$2,122,913.00

1 week

0%

1 month

6.5%

YTD

68.57%

1 year

65.6%

All time high

25.95

Key Fundamentals

EPS 3 yr Growth

-1779.30%

EBITDA Margin

82.30%

Operating Cashflow

-$11m

Free Cash Flow Return

-4.00%

ROIC

49.90%

Interest Coverage

0.00

Quick Ratio

8.70

Other Data

Shares Outstanding (Fully Diluted)

129m

HALO Sector

Healthcare

Next Company Report Date

26-Feb-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.18

NEU Announcements

Latest Announcements

DateAnnouncements
20 October 25
17 October 25
03 October 25
22 September 25
09 September 25

NEU Fundamentals

Per Share Records

Historical data

Forecast data

AUD2020202120222023202220232024202520262027
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklockN/A1.241.11locklocklock
EPS (Fully Diluted)
$locklocklocklockN/A1.21.09locklocklock
Growth
%locklocklocklock102.382,313.3-10.1locklocklock
PE
Xlocklocklocklock1,826.714.311.9locklocklock
EV/EBITDA
Xlocklocklocklock334.911.39.6locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

Short Selling

Key Stats

Percent of Issue

5.15%

Value ($M)

137

Prior Change

0

7 Day Change

-0.20%

1 Month Change

0.30%

3 Months Change

-0.50%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

NEU Shortsell

Want to learn more?Frequently asked questions.
What is the current share price of Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
The current share price of Neuren Pharmaceuticals Limited (NEU:ASX) is AUD$21.40.
What is the 52-week high share price for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
The 52-week high share price for Neuren Pharmaceuticals Limited (NEU:ASX) is AUD$22.99.
What is the 52-week low share price for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
The 52-week low share price for Neuren Pharmaceuticals Limited (NEU:ASX) is AUD$8.61.
What is the dividend yield for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
Neuren Pharmaceuticals Limited (NEU:ASX) does not pay a dividend.
What was Neuren Pharmaceuticals Limited (NEU:ASX) last dividend payment?
Halo FAQ
Neuren Pharmaceuticals Limited (NEU:ASX) does not pay a dividend.
What is the franking level for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
Neuren Pharmaceuticals Limited (NEU:ASX) has a franking level of 0.00%.
In which sector is Neuren Pharmaceuticals Limited (NEU:ASX) classified?
Halo FAQ
Neuren Pharmaceuticals Limited (NEU:ASX) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Neuren Pharmaceuticals Limited (NEU:ASX)?
Halo FAQ
The current P/E ratio for Neuren Pharmaceuticals Limited (NEU:ASX) is 11.90.

See beyond the curve.

One solution for research, investing and portfolio management.